TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10069881

Group type: EXPERIMENTAL
Intervention: Recombinant human IL-5 by nebulization
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle challenge (Control)
Number of subjects: 14
Study: 7496238

Group type: EXPERIMENTAL
Intervention: Disclosure of depression scores to general practitioners for subjects whose depression was undetected (45% of cases, 52 out of 116).
Number of subjects: 179

Group type: COMPARATOR
Intervention: Detected depression cases by general practitioners.
Number of subjects: 179

Group type: COMPARATOR
Intervention: Intention to treat analysis.
Number of subjects: 179

Group type: COMPARATOR
Intervention: Disclosure of undetected depression.
Number of subjects: 179
Study: 2178384

Group type: EXPERIMENTAL
Intervention: milrinone (10 mg 4 times a day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: captopril (50 mg 3 times a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 224478

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus BCG
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 100
Study: 31099213

Group type: EXPERIMENTAL
Intervention: Acupuncture once every day
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Acupuncture once every 2 days
Number of subjects: 180

Group type: COMPARATOR
Intervention: Acupuncture once every 3 days
Number of subjects: 180
Study: 28094662

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 129
Study: 26316598

Group type: EXPERIMENTAL
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 2946

Group type: COMPARATOR
Intervention: Clinical monitoring (CDM)
Number of subjects: 2946

Group type: EXPERIMENTAL
Intervention: Single CD4 test at 48 weeks
Number of subjects: 2946

Group type: EXPERIMENTAL
Intervention: No CD4 testing
Number of subjects: 2946

Group type: EXPERIMENTAL
Intervention: 24-weekly CD4 testing
Number of subjects: 2946
Study: 23159435

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg twice daily)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 21773891

Group type: EXPERIMENTAL
Intervention: Electrocautery (group E)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Scalpel (group S)
Number of subjects: 100
Study: 19714289

Group type: EXPERIMENTAL
Intervention: Transnasal FICE system
Number of subjects: 72
Study: 16394035

Group type: EXPERIMENTAL
Intervention: HPV16 L1 VLP vaccine
Number of subjects: 2391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2391
Study: 15488358

Group type: EXPERIMENTAL
Intervention: Physical activity counseling
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no physical activity counseling)
Number of subjects: 70
Study: 12051309

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9744512

Group type: EXPERIMENTAL
Intervention: Adjuvant treatments (specific treatments not detailed)
Number of subjects: 2687
Study: 7640648

Group type: EXPERIMENTAL
Intervention: Antagonist passive stretch (APS), 6‐sec maximal voluntary isometric contraction (MVIC) of the antagonist, and subsequent APS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Antagonist passive stretch (APS), 6‐sec MVIC of the antagonist, submaximal concentric contraction of the agonist, and APS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Antagonist passive stretch (APS), submaximal concentric contraction of the agonist, and APS (without MVIC)
Number of subjects: 60
Study: 2758730

Group type: EXPERIMENTAL
Intervention: Pinacidil 12.5 mg with Hydrochlorothiazide 12.5 mg
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Pinacidil 37.5 mg monotherapy
Number of subjects: 384

Group type: COMPARATOR
Intervention: Pinacidil (0, 12.5, 25, and 37.5 mg, b.i.d.)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (0, 12.5, and 25 mg, b.i.d.)
Number of subjects: 384
Study: 105443

Group type: EXPERIMENTAL
Intervention: Orgotein injected after each daily irradiation session
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31652241

Group type: EXPERIMENTAL
Intervention: Exergaming (EG) program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Traditional physical exercise (TPE) program
Number of subjects: 29
Study: 30095736

Group type: EXPERIMENTAL
Intervention: Standard countermovement push-up (CMP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Kneeling countermovement push-up (CMP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Drop-fall push-up (CMP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Standard squat push-up (SP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Kneeling squat push-up (SP)
Number of subjects: 37
Study: 28153102

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 3340

Group type: COMPARATOR
Intervention: Control
Number of subjects: 3340
Study: 26077375

Group type: EXPERIMENTAL
Intervention: Non-soya legume-based TLC diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: Isoenergetic legume-free TLC diet
Number of subjects: 31
Study: 23480233

Group type: EXPERIMENTAL
Intervention: Tacrolimus predose concentrations at five time points (day 3, 10, 14, month 1, and month 6 after transplantation)
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: Delayed graft function (DGF)
Number of subjects: 1304

Group type: EXPERIMENTAL
Intervention: Induction therapy
Number of subjects: 1304
Study: 21074910

Group type: EXPERIMENTAL
Intervention: Postoperative immunomodulating enteral diet (IMEN)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Standard oligopeptide diet (SEN)
Number of subjects: 305
Study: 19584344

Group type: EXPERIMENTAL
Intervention: Tubular diskectomy
Number of subjects: 328

Group type: COMPARATOR
Intervention: Conventional microdiskectomy
Number of subjects: 328
Study: 17074301

Group type: EXPERIMENTAL
Intervention: Eight-week cognitive-behavioral workshop (2 hours per week, in groups of 10)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 240
Study: 15447818

Group type: EXPERIMENTAL
Intervention: Glutamine granules (0.5 g.kg(‐1).d(‐1) orally for 7 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (glycine, same dosage for 7 days)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glutamine granules
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (Gln and C)
Number of subjects: 120
Study: 11257247

Group type: EXPERIMENTAL
Intervention: IUD‐Cu 380A
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: IUD‐Cu 200B
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (no IUD)
Number of subjects: 95
Study: 9621674

Group type: EXPERIMENTAL
Intervention: Warmed solution using HOT LINE
Number of subjects: 35

Group type: COMPARATOR
Intervention: Unwarmed solution
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Slow infusion rate
Number of subjects: 35
Study: 30220702

Group type: EXPERIMENTAL
Intervention: Phacoemulsification cataract surgery
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no phacoemulsification cataract surgery)
Number of subjects: 49
Study: 28459932

Group type: EXPERIMENTAL
Intervention: Breastfeeding promotion intervention
Number of subjects: 13557

Group type: COMPARATOR
Intervention: Control group (no breastfeeding promotion)
Number of subjects: 13557
Study: 24062278

Group type: EXPERIMENTAL
Intervention: Canine-assisted intervention (CAI)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy without CAI
Number of subjects: 24
Study: 24001483

Group type: EXPERIMENTAL
Intervention: Immediate open repair
Number of subjects: 2226

Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 2226

Group type: EXPERIMENTAL
Intervention: Immediate open repair (Men)
Number of subjects: 2226

Group type: EXPERIMENTAL
Intervention: Immediate open repair (Women)
Number of subjects: 2226
Study: 19492709

Group type: EXPERIMENTAL
Intervention: Sealing with polyurethane-dimethacrylate foil using a bonding agent
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral home care with dental floss and fluoridated toothpaste (Control)
Number of subjects: 50
Study: 17227498

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg on-demand before sexual activity
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg three times per week for 5-6 weeks
Number of subjects: 4262

Group type: COMPARATOR
Intervention: Tadalafil 20 mg on-demand
Number of subjects: 4262

Group type: COMPARATOR
Intervention: Tadalafil 20 mg three times per week
Number of subjects: 4262
Study: 15593037

Group type: EXPERIMENTAL
Intervention: Ultrapure dialysate
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional dialysate
Number of subjects: 34
Study: 11767810

Group type: EXPERIMENTAL
Intervention: Modified Protocol (MP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional Protocol (TP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pooled sample (excluding dropouts)
Number of subjects: 80
Study: 9648957

Group type: EXPERIMENTAL
Intervention: Omeprazole, 40 mg b.i.d. for 3 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7861594

Group type: EXPERIMENTAL
Intervention: Celiac plexus block (CPB) with 99.5% ethanol 15-20 ml
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Thoracic epidural block (TEB) with 2% lidocaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 2909549

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (25 mg twice daily) with 25-hydroxyvitamin D (50 micrograms twice weekly) and calcium supplements (total calcium intake 1500 mg/day)
Number of subjects: 24
Study: 897571

Group type: EXPERIMENTAL
Intervention: Coenzyme-B12
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cyanocobalamin
Number of subjects: 2
Study: 31439531

Group type: EXPERIMENTAL
Intervention: Topical antiseptic ointment
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Topical decongestant ointment
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Chemical cauterization
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Topical antiseptic ointment + chemical cauterization
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Topical decongestant ointment + chemical cauterization
Number of subjects: 137
Study: 31484191

Group type: EXPERIMENTAL
Intervention: Cynara scolymus (500 mg twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (starch powder)
Number of subjects: 40
Study: 31639167

Group type: EXPERIMENTAL
Intervention: King Vision™ aBlade™ channeled video laryngoscope
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: McGRATH™ MAC video laryngoscope
Number of subjects: 105

Group type: COMPARATOR
Intervention: King Vision™ aBlade™ non‐channeled video laryngoscope
Number of subjects: 105
Study: 28418082

Group type: EXPERIMENTAL
Intervention: Supplementation with resistant starch (RS) and polydextrose (PD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26266387

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 23325750

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Present-Centered Therapy (PCT)
Number of subjects: 86
Study: 21809964

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18926865

Group type: EXPERIMENTAL
Intervention: Exercise 2h after a meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exercise 1h before a meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Meal consumption
Number of subjects: 12
Study: 17713973

Group type: EXPERIMENTAL
Intervention: CP-481,715 (up to 3000 mg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CP-481,715 (300 mg) with ciclosporin
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CP-481,715 (300 mg) without ciclosporin
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CP-481,715 (escalating doses)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 15389187

Group type: EXPERIMENTAL
Intervention: Infliximab 3 mg/kg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 249
Study: 11162416

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol 160/4.5 microg (1 inhalation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol 160/4.5 microg (2 inhalations)
Number of subjects: 30

Group type: COMPARATOR
Intervention: salmeterol/fluticasone 50/250 microg
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 9783305

Group type: EXPERIMENTAL
Intervention: Symptom Score (SS) assessment during treatment for acute lymphoblastic leukemia (ALL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Symptom Score (SS) assessment during treatment for solid tumors receiving megatherapy with autologous bone marrow rescue
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Symptom Score (SS) assessment during treatment for miscellaneous tumors
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Symptom Score (SS) correlation with protein breakdown in paired WBPT studies
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Symptom Score (SS) correlation with fever and neutrophil count
Number of subjects: 30
Study: 7872756

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol (3 g single dose)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Cephalexin (0.5 g four times daily for 5 days)
Number of subjects: 112
Study: 2969740

Group type: EXPERIMENTAL
Intervention: 2 mg doxazosin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 4 mg doxazosin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 8 mg doxazosin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Doxazosin (combined regimens)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 114

Group type: COMPARATOR
Intervention: Doxazosin and Placebo
Number of subjects: 114
Study: 31899950

Group type: EXPERIMENTAL
Intervention: Maize-based diet
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Pelleted diet
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Mash diet
Number of subjects: 360

Group type: COMPARATOR
Intervention: Wheat-based diet
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Cereal type and feed form interaction
Number of subjects: 360
Study: 30833375

Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Blood Glucose (SMBG) ≥80%
Number of subjects: 699

Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG) <80%
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: SMBG% median
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 699
Study: 28833481

Group type: EXPERIMENTAL
Intervention: Number of medications taken
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variability in HbA1c
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total comorbidities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher diastolic blood pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of anti-hypertensives
Number of subjects: 0
Study: 26465253

Group type: EXPERIMENTAL
Intervention: Multifocal IOLs (AcrySof IQ ReSTOR toric or nontoric)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Monofocal IOLs (nontoric only)
Number of subjects: 208
Study: 23966058

Group type: EXPERIMENTAL
Intervention: Weight vest (10 kg) during exercise testing
Number of subjects: 17

Group type: COMPARATOR
Intervention: Weight reduction (WR) through caloric restriction
Number of subjects: 17
Study: 20506126

Group type: EXPERIMENTAL
Intervention: NEVO™ sirolimus-eluting stent with biodegradable polymer
Number of subjects: 1
Study: 19330931

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG) supplementation with standard triple therapy (amoxicillin 25 mg/kg twice per day, clarithromycin 10 mg/kg twice per day, omeprazole 0.5 mg/kg twice per day)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo with standard triple therapy (amoxicillin 25 mg/kg twice per day, clarithromycin 10 mg/kg twice per day, omeprazole 0.5 mg/kg twice per day)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG) supplementation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 17595475

Group type: EXPERIMENTAL
Intervention: Topical diclofenac 0.1%
Number of subjects: 43

Group type: COMPARATOR
Intervention: Dexamethasone 0.1%
Number of subjects: 43
Study: 14987264

Group type: EXPERIMENTAL
Intervention: Epidermolysis bullosa simplex (EBS)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Dominant dystrophic EB (DDEB)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Junctional EB (JEB)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Recessive dystrophic EB (RDEB)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: JEB-Herlitz
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: RDEB-Hallopeau-Siemens
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: JEB-non-Herlitz
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Other RDEB subtypes
Number of subjects: 140
Study: 11120491

Group type: EXPERIMENTAL
Intervention: Cold knife surgical excision
Number of subjects: 59
Study: 9873261

Group type: EXPERIMENTAL
Intervention: Blood donors
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: Children infected with HCV via blood transfusion
Number of subjects: 968
Study: 7761553

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2723127

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and saline
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.6 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.45 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.3 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.15 mg
Number of subjects: 6
Study: 30867017

Group type: EXPERIMENTAL
Intervention: 10-min treadmill walking program (Ex)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Joint mobilisation (MB) of the thoracic spine and ribs plus the same walking program (MB + Ex)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Joint manipulation (MT) of the thoracic spine and ribs plus the same walking program (MT + Ex)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 372
Study: 29794761

Group type: EXPERIMENTAL
Intervention: Conventional acupuncture + thread embedding acupuncture
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 38
Study: 26521178

Group type: EXPERIMENTAL
Intervention: MDMA (125 mg)
Number of subjects: 15
Study: 24564568

Group type: EXPERIMENTAL
Intervention: Hand tapping
Number of subjects: 237
Study: 22271702

Group type: EXPERIMENTAL
Intervention: Outpatient, oral amoxicillin plus ciprofloxacin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Continued standard treatment (intravenous antimicrobial therapy)
Number of subjects: 62
Study: 20010073

Group type: EXPERIMENTAL
Intervention: Planned treatment interruptions (PTI)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Continuous therapy
Number of subjects: 109
Study: 17187491

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valproate combined with lithium or antipsychotic drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Valproate (serum levels 75-99 microg/ml)
Number of subjects: 0
Study: 16004253

Group type: EXPERIMENTAL
Intervention: Calcium carbonate/perlite whitening toothpaste
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Silica containing whitening toothpaste
Number of subjects: 25
Study: 12235618

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home discharge
Number of subjects: 0
Study: 10378906

Group type: EXPERIMENTAL
Intervention: Plasma volume expansion (PVexp) with 6% dextran
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham plasma volume expansion (Sham)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Restoration of normocythemia
Number of subjects: 9

Group type: COMPARATOR
Intervention: Reestablishment of normocythemia
Number of subjects: 9
Study: 7758641

Group type: EXPERIMENTAL
Intervention: Abdominal hysterectomy with unilateral oophorectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Abdominal hysterectomy only (preservation of both ovaries)
Number of subjects: 40
Study: 2129317

Group type: EXPERIMENTAL
Intervention: pentaerythril tetranitrate (PETN)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate (ISDN)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: oral nitrate therapy
Number of subjects: 34
Study: 7275281

Group type: EXPERIMENTAL
Intervention: 500 ml of stored serum Biseko on the day of operation and the first postoperative day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30712946

Group type: EXPERIMENTAL
Intervention: Living Successfully with Low Vision (LSLV) program, N = 83
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care (LV aid training only), N = 82
Number of subjects: 165
Study: 28290144

Group type: EXPERIMENTAL
Intervention: Loss-framed message emphasizing the harms of smoking
Number of subjects: 279

Group type: COMPARATOR
Intervention: Gain-framed message communicating the benefits of avoiding smoking
Number of subjects: 279

Group type: COMPARATOR
Intervention: Neutral message
Number of subjects: 279
Study: 25791462

Group type: COMPARATOR
Intervention: OCP alone (n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: OCP combined with metformin (n=25)
Number of subjects: 50